Table 1.
Characteristics of the 23 Patients
| Characteristic | Data |
|---|---|
| Age at scanning (y) | |
| Mean | 68 |
| Range | 55-85 |
| Gleason score | |
| 6-7 | 2 (8%) |
| 8-9 | 21 (92%) |
| PSA at scanning (ng/dl) | |
| Mean | 80.85 |
| Range | 0.380-517 |
| Risk group | |
| Intermediate | 2 (8%) |
| High | 21 (92%) |
| Previous treatment | |
| HT | 17 (73%) |
| RT | 5 (21%) |
| QT | 8 (34%) |
| Ra-223 | 2 (8%) |
| None | 2 (8%) |
Abbreviations: HT = androgen deprivation therapy (including bicalutamide and LHRH); RT = radiotherapy; QT = chemotherapy (docetaxel); Ra-223 = radium-223. Data are followed by percentage in parentheses, except for age.